These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 23557402

  • 1. NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas.
    Morin P, Ferguson D, LeBlanc LM, Hébert MJ, Paré AF, Jean-François J, Surette ME, Touaibia M, Cuperlovic-Culf M.
    J Proteome Res; 2013 May 03; 12(5):2165-76. PubMed ID: 23557402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structure-activity relationship of caffeic acid phenethyl ester analogs as new 5-lipoxygenase inhibitors.
    Doiron JA, Leblanc LM, Hébert MJ, Levesque NA, Paré AF, Jean-François J, Cormier M, Surette ME, Touaibia M.
    Chem Biol Drug Des; 2017 Apr 03; 89(4):514-528. PubMed ID: 27717142
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H, Huang X, Xu S, Shen H, Zhang P, Huang Y, Jiang J, Sun Y, Jiang B, Wu X, Yao H, Xu J.
    Eur J Med Chem; 2016 Jan 27; 108():89-103. PubMed ID: 26638042
    [Abstract] [Full Text] [Related]

  • 8. New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition.
    Chiasson AI, Robichaud S, Ndongou Moutombi FJ, Hébert MPA, Mbarik M, Surette ME, Touaibia M.
    Molecules; 2020 Oct 14; 25(20):. PubMed ID: 33066378
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
    De Lucia D, Lucio OM, Musio B, Bender A, Listing M, Dennhardt S, Koeberle A, Garscha U, Rizzo R, Manfredini S, Werz O, Ley SV.
    Eur J Med Chem; 2015 Aug 28; 101():573-83. PubMed ID: 26197161
    [Abstract] [Full Text] [Related]

  • 11. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW.
    Int J Immunopharmacol; 1992 Apr 28; 14(3):505-10. PubMed ID: 1618602
    [Abstract] [Full Text] [Related]

  • 12. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS, Hardy MM, Anderson GD, Dufield DR, Pufahl RA, Masferrer JL.
    Eur J Pharmacol; 2008 Apr 14; 584(1):166-74. PubMed ID: 18295198
    [Abstract] [Full Text] [Related]

  • 13. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties.
    Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD.
    FEBS Lett; 1993 Aug 23; 329(1-2):21-4. PubMed ID: 7689063
    [Abstract] [Full Text] [Related]

  • 14. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.
    Li CT, Zhang WP, Lu YB, Fang SH, Yuan YM, Qi LL, Zhang LH, Huang XJ, Zhang L, Chen Z, Wei EQ.
    J Neurosci Res; 2009 Mar 23; 87(4):991-1001. PubMed ID: 18951527
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro antıneoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives.
    Akyol S, Ozturk G, Ginis Z, Armutcu F, Yigitoglu MR, Akyol O.
    Nutr Cancer; 2013 Mar 23; 65(4):515-26. PubMed ID: 23659443
    [Abstract] [Full Text] [Related]

  • 16. Constituents of Chinese propolis and their antiproliferative activities.
    Usia T, Banskota AH, Tezuka Y, Midorikawa K, Matsushige K, Kadota S.
    J Nat Prod; 2002 May 23; 65(5):673-6. PubMed ID: 12027739
    [Abstract] [Full Text] [Related]

  • 17. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.
    Selka A, Doiron JA, Lyons P, Dastous S, Chiasson A, Cormier M, Turcotte S, Surette ME, Touaibia M.
    Eur J Med Chem; 2019 Oct 01; 179():347-357. PubMed ID: 31260889
    [Abstract] [Full Text] [Related]

  • 18. Theoretical, antioxidant and cytotoxic activities of caffeic acid phenethyl ester and chrysin.
    Sulaiman GM, Al-Amiery AA, Bagnati R.
    Int J Food Sci Nutr; 2014 Feb 01; 65(1):101-5. PubMed ID: 24020631
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
    Venugopala KN, Govender R, Khedr MA, Venugopala R, Aldhubiab BE, Harsha S, Odhav B.
    Drug Des Devel Ther; 2015 Feb 01; 9():911-21. PubMed ID: 25733811
    [Abstract] [Full Text] [Related]

  • 20. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL.
    Cancer Res; 1999 May 01; 59(9):2223-8. PubMed ID: 10232612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.